Track topics on Twitter Track topics that are important to you
Nerves of the central nervous system may begin flexing regenerative powers if they can be induced to express a protein normally found in muscle cells. These nerves won’t even have to submit to any grueling exercise routines. Instead, they may benefit from gene therapy, a new study suggests. According to a team of scientists based […] The post Nerve Regeneration Pumped Up by Muscle Protein ...
NewsThe world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments.
Pediatric #Brain Tumors Shrink from Epigenome Targeted Therapy: http://ow.ly/UQcH30nqcA9 pic.twitter.com/sEwiQXUJBm
Scientists at Sanford Burnham Prebys Medical Discovery Institute have reported that a targeted therapy, which blocks a protein called LSD1, was able to shrink tumors in mice with medulloblastoma. LSD1 inhibitors are currently under evaluation in clinical trials for other cancers, which could speed their potential path to children with medulloblastoma. The post Pediatric Brain Tumors Shrink from Ep...
Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them.
A scientist at Johns Hopkins has published a paper (“Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett’s Esophagus: A Prospective Validation Study”) in Clinical Cancer Research that he says could finally result in simple and inexpensive screening for esophageal cancer. “Barrett’s esophagus (BE) is the only known precursor of esophageal a...
Eurydice Roman’s film Au Type Documentary highlights CARD as a premier source for behavioral health treatment and for its efforts to increase autism awareness. NEW YORK (PRWEB) January 23, 2019 Center for Autism and Related Disorders (CARD) will be featured in a forthcoming documentary about resources for families in New York City’s autism community. Eurydice Roman’s film Au Type Documentar...
Zero+ Nutraceutical and its CO-Founder Bob Mordini will be a featured guest on Modern Living with kathy ireland® in 2019. The feature story will be broadcast globally on WE tv (as sponsored programming) and Bloomberg Worldwide a few weeks after the live taping. Rachel M. Ragsdale, LPC, BCN NeurOptimize - Founder and CEO will be joining Mr. Mordini on the show. Her company provides cutting edg...
The company published good results for its urinary tract cancer treatment, which it hopes to launch this year.
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the addition of Elizabeth (Liz) Barrett and George Golumbeski, Ph.D., to the company’s board of directors. “We are extremely pleased to add these two experienced ...
This is entertaining: on fly- and mini-brain science, #cryoEM, the elusive secret of the @MRC_LMB's Nobel Prize factory, and collaboration on the @CamBioCampus, e.g. with @AstraZeneca. Starring, aomng others, @MinibrainLab, @lapassmore and @gsxej. https:/
This is entertaining: on fly- and mini-brain science, #cryoEM, the elusive secret of the @MRC_LMB's Nobel Prize factory, and collaboration on the @CamBioCampus, e.g. with @AstraZeneca. Starring, aomng others, @MinibrainLab,
In the search for signs of cancer, a team at @BostonChildrens is turning to an unlikely source: urine.
Un test plus rapide et moins coûteux permettant de prévoir le risque de métastases chez les patients atteints d'un cancer de la prostate, c’est ce que nous promet cette équipe du Collège de médecine Albert Einstein (Bronx, NY). Il s’agit d’un test de modification du nombre de copies, de nouvelle génération car capable d’analyser de […]
05/21/12 Bioresearch Online Newsletter
06/04/12 Bioresearch Online Newsletter
04/19/12 Bioresearch Online Newsletter
Since the war on cancer was first declared, nearly half of those diagnosed today will be cured. Despite this incredible progress, cancer continues to gain ground, recently becoming the number one killer in 22 U.S. states.
This is the concluding installment of our three-part series on new therapeutic mechanisms for neurodegenerative diseases. Here, as in the first two parts, we have brought together a “virtual roundtable” comparing the views of key scientific opinion leaders with some of the companies developing new therapeutics for progressive MS. (See Part One, “Aiming at Alzheimer’s,&rdquo...
I want to share how the era of immunotherapy, specifically immune-checkpoint-inhibitors, has changed the landscape of community oncology practice in metastatic non-small-cell lung cancer, for oncologists and, more importantly, patients. I want to tell you the story of Joe. A stage IV lung cancer survivor story. (Name and details changed to protect anonymity.) In 2015, Joe […] Find jobs at ...
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approach...
Cancer Network spoke with Dr. Bassel El-Rayes about novel strategies on the horizon for pancreatic cancer during the 2019 ASCO Gastrointestinal Cancers Symposium.
Cancer Network spoke with Dr. Daniela Molena about the advancements in the treatment of esophageal cancer, including the safety and importance of endoscopic resection for the disease.
James Nathanielsz, CEO of Propanc Biopharma, talks about preclinical development, funding, cancer stem cells and more. The post Propanc’s Cancer Stem Cell Technology Ready for the Clinic appeared first on Investing News Network.
International research team identifies a blood marker that they hope could lead to a cheap and simple test for #Alzheimer's: http://ow.ly/h2Lv30npnup
NewsResearchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.